NS

Nimmakayala Sree Devi

Active Director Director DIN 11222720
DIN 11222720 First appointment Aug 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Nimmakayala Sree Devi

Data last updated:

Nimmakayala Sree Devi is a Director at Indosynth Laboratories Private Limited (since 2025). The company operates in Chemicals. Indosynth Laboratories Private Limited reported revenue of ₹3.43 Cr (FY 2025).

DIN 11222720
Primary Designation Director
Industry Chemicals
First Appointment 01 Aug 2025
Largest company Indosynth Laboratories Private Limited · ₹3.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 2025₹3.43 Cr (FY 2025)Active

Board colleagues of Nimmakayala Sree Devi

Directorship timeline

Open interactive timeline →
Indosynth Laboratories Private Limited
Premium access

Shareholding and investment profile for Nimmakayala Sree Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nimmakayala Sree Devi

Nimmakayala Sree Devi currently holds 1 directorship: Indosynth Laboratories Private Limited (Director, since 01 Aug 2025, revenue ₹3.43 Cr (FY 2025)).

Nimmakayala Sree Devi was first appointed on 01 Aug 2025 as Director at Indosynth Laboratories Private Limited.

The current boards of Nimmakayala Sree Devi's companies include Mallikarjuna Reddy Nimmakayala (Indosynth Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available